Vanadium-Coated Orthopedic Implants for Accelerated Bone Healing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bone fractures, especially in diabetic patients and those with impaired bone healing, are inefficient and often lead to delayed union or non-union, with existing therapies requiring specialized methods and storage, and having potential systemic complications.
Innovation Solution
An implantable device coated with a composite surface layer containing an insulin-mimetic organovanadium compound, such as vanadyl acetylacetonate, is used to promote bone healing by enhancing the material properties of orthopedic devices and accelerating bone regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional orthopedic devices are used for bone fracture treatment, then device simplicity and ease of manufacture are maintained, but bone healing speed and strength are insufficient, especially in diabetic patients
Solution Approach 1:
The patent applies composite materials by coating orthopedic devices with a multi-layer structure consisting of a metal boride layer and an insulin-mimetic organovanadium compound layer. This composite coating combines the mechanical strength of metal borides with the bone-healing properties of vanadium compounds, achieving accelerated fracture healing without complicating the base device structure
Solution Approach 2:
The patent implements local quality by applying the insulin-mimetic organovanadium compound coating specifically to the surface regions of the orthopedic device that contact bone tissue. This localized application concentrates the therapeutic effect at the fracture site while maintaining simplicity in other parts of the device
2Productivity
If growth factors are added to enhance bone healing, then bone regeneration is accelerated, but storage requirements and device complexity increase
Solution Approach 1:
The patent uses vanadium compounds that can be applied directly to the device surface and provide sustained therapeutic effect without requiring complex storage conditions. The coating is applied once during manufacturing and remains effective throughout the device's service life, eliminating the need for specialized storage infrastructure
Solution Approach 2:
The patent changes the chemical parameters of the device surface by coating it with insulin-mimetic organovanadium compounds. This chemical modification enables the device to stimulate bone healing through biochemical interaction rather than requiring additional biological agents like growth factors
3Reliability
If systemic vanadium therapy is used to control diabetes, then glycemic control is improved, but bone parameter effects are not achieved in non-diabetic models
Solution Approach 1:
The patent applies vanadium compounds locally to the orthopedic device surface rather than using systemic administration. This localized application ensures high concentration of the active compound at the fracture site where it directly contacts bone tissue, achieving bone-healing effects that systemic therapy fails to produce
4Productivity
If high concentration vanadium is used to stimulate osteoblast proliferation, then bone formation is enhanced, but inhibition effects occur at high concentrations
Solution Approach 1:
The patent applies vanadium compounds as a surface coating on orthopedic devices, creating a localized high-concentration zone at the fracture site. This localized application delivers sufficient vanadium to stimulate osteoblast proliferation where needed while limiting systemic exposure and avoiding toxic effects
Solution Approach 2:
The patent uses a thin film coating of insulin-mimetic organovanadium compounds on the device surface. This thin film provides controlled release of vanadium ions, maintaining therapeutic concentrations at the bone interface while preventing excessive accumulation that would cause toxicity
Data Source
Figure 1A~2F
Figure 3~4
Figure 5
AI summary
The present invention discloses vanadium-based insulin-mimetic agent composite coatings, application of these coatings onto implantable devices, and use of the implantable devices for accelerating osseous healing. The invention also encompasses methods of manufacturing implantable devices coated with vanadium-based insulin- mimetic agent composite coatings and the implantable devices so manufactured. The implantable devices have wide applications, including but not limited to treating bone fracture, bone trauma, arthrodesis, and other bone deficit conditions, as well as bone injuries incurred in military and sports activities.